| Code | Description | Claims | Beneficiaries | Total Paid |
| 99223 |
Prolong inpt eval add15 m |
845 |
800 |
$67K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,472 |
1,063 |
$50K |
| 99220 |
|
600 |
502 |
$41K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
819 |
704 |
$37K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,444 |
1,147 |
$34K |
| 99219 |
|
500 |
392 |
$27K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
639 |
499 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
123 |
120 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
149 |
128 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
273 |
212 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
268 |
182 |
$7K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
75 |
72 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
323 |
284 |
$5K |
| 99222 |
Initial hospital care, per day, moderate complexity |
64 |
58 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30 |
27 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
45 |
32 |
$2K |
| 96160 |
|
96 |
76 |
$1K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19 |
15 |
$924.80 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
22 |
22 |
$672.95 |